Trial intelligence / Profile preview

Effects of Omeprazole on Postprandial Amino Acid Concentrations

NCT07142486Completed

Sponsor
McGill University
Start
Sep 2025
Primary completion
Jun 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in gastroesophageal reflux disease (GERD) and gastric ulcer comparing Omeprazole 20mg capsule with Placebo (2 arms). Primary endpoint: Incremental Area Under the Curve for Total Plasma Amino Acid Concentrations. Started Sep 2025; status: completed.

02

Drugs

omeprazole
03

Conditions

gastroesophageal reflux disease (GERD)gastric ulcer

Beyond the preview

Go deeper on NCT07142486.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07142486.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call